Multimodal anesthesia associated with regional block in a dog who underwent corrective surgery for persistent right aortic arch: case report / Anestesia multimodal associada a bloqueio loco-regional em cão submetido a cirurgia corretiva para persistência de arco aórtico direito: relato de caso

The persistence of the fourth right aortic arch (PRAA) is a congenital malformation that affects the heart base's main vessels. Surgical treatment is recommended and should be advocated as a matter of urgency. In this context, efficient anesthesia planning is necessary, with satisfactory analgesia, associating multimodal techniques with regional blocks. The present work aims to report the anesthetic procedure during corrective surgery for PRAA in a dog. Neuroleptanalgesia was intramuscularly performed, using acepromazine (0.015 mg.kg-1) and methadone (0.3 mg.kg-1) in pre-anesthetic medication. Ketamine (1 mg.kg-1) and propofol (3 mg.kg-1) were administered at induction, both intravenously, followed by maintenance using total intravenous anesthesia with propofol (initial rate of 0.4 mg.kg-1 .minute) and remifentanil, (0.2 mcg.kg.-1.minute). In addition, ultrasound-guided regional intercostal block was performed, with 5% bupivacaine without vasoconstrictor (0.05ml.kg-1). Ketamine infusion was postoperatively maintained for one hour. The instituted protocol proved to be satisfactory in controlling trans and postoperative pain, maintaining all parameters stable during and after the procedure, without any intercurrence. Thus, the protocol provided quality recovery to the patient.(AU)

A persistência do quarto arco aórtico direito é uma má formação congênita, afetando os principais vasos da base cardíaca. O tratamento cirúrgico é recomendado e preconiza-se um planejamento anestésico eficiente, associando-se técnicas multimodais a bloqueios regionais. O presente trabalho objetiva relatar a anestesia durante cirurgia corretiva de PDA em cão. Na medicação pré-anestésica, instituiu-se neuroleptonalgesia, utilizando-se acepromazina (0,015 mg.kg-1) e metadona (0,3 mg.kg-1), por via intramuscular. Na indução, foi administrada cetamina (1mg.kg -1) e propofol (3 mg.kg-1). Para manutenção, utilizou--se propofol (taxa inicial de 0,4 mg.kg-1.minuto) e remifentanil, (0,2 mcg.kg-1.minuto). Além disso, foi realizado bloqueio regional intercostal guiado por ultrassom com bupivacaína sem vasoconstritor a 5% (0,05ml.kg-1). O paciente permaneceu em infusão analgésica de cetamina por uma hora, no pós operatório. O protocolo estabelecido demonstrou ser satisfatório no controle de dor trans e pós-operatória, mantendo todos os parâmetros estáveis, sem nenhuma intercorrência, proporcionando qualidade de recuperação ao paciente.(AU)

Histoplasmose nasocutânea em gato / Nasocutaneous histoplasmosis in cat

Histoplasmosis is a systemic fungal disease of an opportunistic nature that affects humans and animals. The objective of this work were to report a clinical case of histoplasmosis in a cat. In the Veterinary Hospital Professor Sylvio Barbosa Cardoso (HVSBC) a cat, no defined breed, female, of four years of age. No cytopathological examination was obtained through histoplasma spp. without cytoplasm of macrophages. Itraconazole in suspension (40 mg / mL / SID) was prescribed for the patient. On the return of the animal, after 21 days of treatment, it was not printed on a readiness scale, then the same drug was prescribed with dose adjustment (50 mg / capsule / SID for 90 days) and pharmaceutical form, and after 38 days was remission of the nasal region.(AU)

Histoplasmose nasocutânea em gato / Nasocutaneous histoplasmosis in cat

Histoplasmosis is a systemic fungal disease of an opportunistic nature that affects humans and animals. The objective of this work were to report a clinical case of histoplasmosis in a cat. In the Veterinary Hospital Professor Sylvio Barbosa Cardoso (HVSBC) a cat, no defined breed, female, of four years of age. No cytopathological examination was obtained through histoplasma spp. without cytoplasm of macrophages. Itraconazole in suspension (40 mg / mL / SID) was prescribed for the patient. On the return of the animal, after 21 days of treatment, it was not printed on a readiness scale, then the same drug was prescribed with dose adjustment (50 mg / capsule / SID for 90 days) and pharmaceutical form, and after 38 days was remission of the nasal region.